Applied Therapeutics, Inc. — Director's Dealing 2019

May 29, 2019

SEC Form 4/A — Form 4/A

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-16

Reporting Person: Shendelman Shoshana (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-16	Common Stock	C	88397	—	Acquired	88397	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-16	Series A Preferred Stock	$	C	88397	Disposed		Common Stock (88397)	Indirect

Footnotes

F1: Each share of Series A Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on May 16, 2019.

F2: These securities were unintentionally omitted from the Reporting Person's initial Form 4.

F3: The reportable securities are directly owned by Clearpoint Strategy Group LLC ("Clearpoint") of which the Reporting Person is the sole owner. The Reporting Person has sole voting and dispositive power over these securities.